Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Europe sees sharp decline in GMO research

Nature Biotechnology volume 21, pages 468–469 (2003)Cite this article

Field trials of genetically modified (GM) crops in the European Union (EU) have plummeted by 87% since 1998, according to a European Commission (EC) investigation. The last European approval for GM crop planting was granted in October 1998, and in 1999 the EU placed a formal moratorium on all new marketing applications for genetically modified organisms (GMOs) until a new legal framework could be agreed on. As a result, requests to start European field trials of GM crops have fallen from the 1998 peak of 254 to only 61 in 2001 and an estimated 33 in 2002. By contrast, notifications of GM trials in the US are running at between 900 and 1,100 a year.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

Author information

Authors and Affiliations

  1. London, UK

    Peter Mitchell

Authors
  1. Peter Mitchell
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Mitchell, P. Europe sees sharp decline in GMO research. Nat Biotechnol 21, 468–469 (2003). https://doi.org/10.1038/nbt0503-468

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0503-468

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing